Life Sciences Newsletter – September 2023

Frier Levitt is pleased to share the latest edition of our Life Sciences Newsletter. Keeping you informed on current topics impacting pharmacies, drug manufacturers, and plan sponsors.

Topics include the impact of PCMA v. Mulready on independent pharmacies, FDA’s delay of DSCSA electronic interoperability, state fair pricing laws, hearings from the House Oversight Committee on the role of PBMs, Patients Before Middlemen Act, and more.

Additionally, stay up to date on upcoming webinars as well as Frier Levitt attorney media mentions.

Share: